Clinical trial
OPTIMIZE-APT: Tailored Versus Conventional Antiplatelet Therapy After Intravascular Imaging-guided Drug-eluting Stent Implantation
NCT05418556 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OPTIMIZE-APT: Tailored Versus Conventional Antiplatelet Therapy After Intravascular Imaging-guided Drug-eluting Stent Implantation
- Lead sponsor
- Asan Medical Center
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 21, 2022
- Completion date
- December 31, 2032
- Enrollment
- 3,944 (estimated)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.